2015 Harrington Scientific Symposium
The third annual Harrington Scientific Symposium brought together physician-scientist inventors, pharmaceutical industry mentors, entrepreneurs, and scientific leaders to celebrate the transformation of medical discovery and the crucial role of physician-scientists. At the symposium, Harrington scholars presented their latest discoveries, and over two days, the 180 symposium presenters and attendees learned about research that promises to advance the standard of care in medicine and save lives.
The 2015 symposium opened with a Keynote Lecture from David Ginsberg, MD, James V. Neel Distinguished University Professor of Internal Medicine and Human genetics, member of the Life Sciences Institute at the University of Michigan medical school, Howard Hughes Medical Institute Investigator, and member of the Harrington Discovery Institute Scientific Advisory Board. Dr. Ginsburg, an internationally known expert on the clotting mechanism and coagulation disorders, cloned the gene for von Willebrand factor as a post-doctoral fellow. His contributions to the field also include the discovery of the genes responsible for combined factor V and VIII deficiency (LMAN1, MCFD@) and thrombotic thrombocytopenic purpura, (ADAMTS13).
Highlights of the scientific sessions include opening remarks on the importance of physician-scientists to medicine and society by Andrew Schafer, MD, Professor of Medicine in Hematology-Oncology and Director of the Richard T Silver Center for Myeloproliferative Neoplasms, Weill Cornell Medical College. Presentations by the 2015 Harrington Scholar-Innovators, the second class of Oxford-Harrington Scholars and the second class of Alzheimer’s Drug Discovery Foundation-Harrington Scholars took place at the Cleveland Institute of Music in University Circle. Mukesh Jain, MD, Harrington Discovery Institute Scientific Director, and Daniel Simon, MD, President, UH Harrington Heart & Vascular Institute moderated the sessions.
Symposium events also featured remarks by: Thomas F. Zenty III, University Hospitals CEO; entrepreneur and philanthropist Ronald Harrington; and discussions of the Harrington Scholar experience by 2013 and 2014 Harrington Scholar-Innovators. A dinner honoring the Harrington Scholars was highlighted by remarks from Douglas Lowy, MD, Acting Director, National Cancer Institute and 2015 awardee of The Harrington Prize for Innovation in Medicine.
Two compelling themes emerged from the 2015 Scientific Symposium. The first is the need for thoughtfully designed bridges that facilitate the journey of accelerating discoveries to medicines, a need that is validated by The Harrington Project model which has already successfully advanced several programs to commercial partners. The second is the value of convening – the importance of having time together to expand our intellectual horizons and explore new directions for greater success. At the symposium, researchers and drug development experts connected, facilitating dialogue that is essential to realizing the commercial potential of groundbreaking scientific discoveries.